- Home
- NDLS vs TELA Comparison
NDLS vs TELA Comparison
Compare NDLS & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDLS
- TELA
- Stock Information
- Founded
- NDLS 1995
- TELA 2012
- Country
- NDLS United States
- TELA United States
- Employees
- NDLS N/A
- TELA N/A
- Industry
- NDLS Restaurants
- TELA Medical/Dental Instruments
- Sector
- NDLS Consumer Discretionary
- TELA Health Care
- Exchange
- NDLS Nasdaq
- TELA Nasdaq
- Market Cap
- NDLS 32.9M
- TELA 80.7M
- IPO Year
- NDLS 2013
- TELA 2019
- Fundamental
- Price
- NDLS $0.90
- TELA $2.02
- Analyst Decision
- NDLS Strong Buy
- TELA Strong Buy
- Analyst Count
- NDLS 2
- TELA 4
- Target Price
- NDLS $3.00
- TELA $6.00
- AVG Volume (30 Days)
- NDLS 223.1K
- TELA 70.8K
- Earning Date
- NDLS 08-06-2025
- TELA 08-11-2025
- Dividend Yield
- NDLS N/A
- TELA N/A
- EPS Growth
- NDLS N/A
- TELA N/A
- EPS
- NDLS N/A
- TELA N/A
- Revenue
- NDLS $495,670,000.00
- TELA $71,217,000.00
- Revenue This Year
- NDLS $5.37
- TELA $26.67
- Revenue Next Year
- NDLS $0.68
- TELA $22.63
- P/E Ratio
- NDLS N/A
- TELA N/A
- Revenue Growth
- NDLS N/A
- TELA 12.78
- 52 Week Low
- NDLS $0.55
- TELA $0.86
- 52 Week High
- NDLS $1.83
- TELA $5.18
- Technical
- Relative Strength Index (RSI)
- NDLS 61.53
- TELA 62.40
- Support Level
- NDLS $0.66
- TELA $1.85
- Resistance Level
- NDLS $0.82
- TELA $1.94
- Average True Range (ATR)
- NDLS 0.08
- TELA 0.18
- MACD
- NDLS 0.02
- TELA 0.01
- Stochastic Oscillator
- NDLS 93.68
- TELA 79.69
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.